🔎 Trials Near Me

Home › Colorectal Cancer › Virginia › Arlington

Pag-aaral pangklinika para sa Colorectal Cancer sa Arlington, VA

Isang pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Nagre-recruitPhase 1
  • NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07454642

The Vanguard Study: Testing a New Way to Screen for Cancer

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
  • Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06995898

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

Nagre-recruitPhase 2
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07659795

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1
  • Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Nagre-recruitPhase 1/2
  • Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
  • Virginia Cancer Specialists, PC, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06324357

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Nagre-recruitPhase 1
  • ALX Center 2, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07085091

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Virginia Cancer Specialists, PC, Arlington
  • Virginia Cancer Specialists, PC, Fairfax · 11 mi ang layo
  • Virginia Cancer Specialists, PC, Reston · 14 mi ang layo
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 2
  • Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06820463

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Nagre-recruitPhase 3
  • Virginia Cancer Specialists, Arlington
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Nagre-recruitPhase 3
  • Virginia Cancer Specialists, Arlington
  • Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06662786

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Nagre-recruitPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Nagre-recruitPhase 1/2
  • Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07629960

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Nagre-recruitPhase 1
  • NEXT - Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07349537

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Nagre-recruitPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05786924

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1
  • NEXT Oncology, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06440005

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Clinical Study Site, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07228832

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Nagre-recruitPhase 2
  • Inova Schar Cancer, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06992258

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06983743

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Nagre-recruitPhase 1
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07227168

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Nagre-recruitPhase 1
  • NEXT Oncology, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07321106

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07066657

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Clinical Trial Site, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Nagre-recruitPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

Nagre-recruitPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07397338

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04657068

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1
  • Next Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07094113

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06657144

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Nagre-recruitPhase 2
  • Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11 mi ang layo
  • Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT07023289

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

Nagre-recruitPhase 1
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT07300150

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Nagre-recruitPhase 1/2
  • NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07169734

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Nagre-recruitPhase 1
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07458347

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Nagre-recruitPhase 1
  • NEXT Texas LLC - Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT07503808

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Nagre-recruitPhase 1
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT07540572

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Nagre-recruitPhase 1
  • Research Site, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Nagre-recruitPhase 1
  • NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06040541

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Nagre-recruitPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 28, 2026 · NCT07223047

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Nagre-recruitPhase 1
  • NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT07094204

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2
  • Next Oncology Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Nagre-recruitPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 24, 2026 · NCT06385925

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Nagre-recruitPhase 1
  • NEXT Virginia, LLC, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT06720987

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Nagre-recruitPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT07020221

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Nagre-recruitPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06395519

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Nagre-recruitPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT06244771

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT07030257

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Nagre-recruitPhase 1/2
  • NEXT, Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT07145255

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1
  • NEXT Virginia, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07317505

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Nagre-recruitPhase 1
  • Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT05856981

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1
  • Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 26, 2024 · NCT05746897

Pag-aaral para sa Colorectal Cancer sa ibang lungsod

Iba pang pag-aaral sa Arlington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.